Skip to main content

RiverGlades Family Offices LLC

Family Office

Position in NVS — Novartis AG

CIK 1619779 NAPLES, FL

Position in NVS

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$360,456
+$9,131 QoQ
Shares Held
2,300
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#1,035
of 1,603 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

RiverGlades Family Offices LLC holds $899,000 across 2 Drug Manufacturers - General names. NVS ranks #2 (40.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NVS
Novartis AG
This page
2,300 $360,456

All Filings in NVS

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $360,456 2,300
2026-03-31 $351,325 2,300
2025-09-30 $359,072 2,800
2025-06-30 $338,828 2,800
2025-03-31 $312,144 2,800
2024-12-31 $272,468 2,800
2024-09-30 $322,056 2,800
2024-06-30 $298,088 2,800
2024-03-31 $270,844 2,800
2023-12-31 $282,716 2,800
2023-09-30 $285,208 2,800
2023-06-30 $282,548 2,800
2023-03-31 $257,600 2,800
2022-12-31 $442,260 4,875
2022-06-30 $412,083 4,875
2022-03-31 $427,781 4,875
2021-12-31 $426,416 4,875
2021-09-30 $398,677 4,875
2021-06-30 $444,795 4,875
2021-03-31 $416,715 4,875
2020-12-31 $460,346 4,875
2020-09-30 $423,930 4,875
2020-06-30 $425,782 4,875
2020-03-31 $401,943 4,875